Abstract
A large number of liposome-based non-viral gene and siRNA delivery systems include monovalent cholesteryl cytofectins with acyclic head groups in their formulations. Progress in their clinical development has, however, been hampered by relatively low transfection efficiencies. Structural differences between members of this class of cationic amphiphiles are located primarily in their linker, spacer and head group regions. This review examines the structural diversity encountered in each of these domains and seeks to identify those features linked to favourable transfection activity. Thus the ether linker, with its greater chemical and metabolic stability, is associated with higher transfection activity than ester, amide or carbamoyl tethers. While a medium length 6 atom spacer in the ether series is preferred over shorter spacers for enhanced activity, short (2 atom) to long (11 atom) spacers are effective in the more common carbamoyl series. For largely historic reasons, the dimethylamino head group has remained a popular cationic centre, but several studies have shown that the N-hydroxyethyl secondary amine functionality may be more effective in cytofectins. This observation has been attributed, in part, to the increased hydrophilicity of the head group and facilitated release of the nucleic acid cargo from liposomes in endosomal compartments. However, the hypothesis that the incorporation of each of these favourable chemical features into a single novel cytofectin may lead to superior transfection activity remains to be fully tested.
Keywords: Cholesterol, cytofectin, gene delivery, liposomes, monovalent, review.
Current Pharmaceutical Biotechnology
Title:Liposomal Formulation of Monovalent Cholesteryl Cytofectins with Acyclic Head Groups and Gene Delivery: A Systematic Review
Volume: 16 Issue: 10
Author(s): Mario Ariatti
Affiliation:
Keywords: Cholesterol, cytofectin, gene delivery, liposomes, monovalent, review.
Abstract: A large number of liposome-based non-viral gene and siRNA delivery systems include monovalent cholesteryl cytofectins with acyclic head groups in their formulations. Progress in their clinical development has, however, been hampered by relatively low transfection efficiencies. Structural differences between members of this class of cationic amphiphiles are located primarily in their linker, spacer and head group regions. This review examines the structural diversity encountered in each of these domains and seeks to identify those features linked to favourable transfection activity. Thus the ether linker, with its greater chemical and metabolic stability, is associated with higher transfection activity than ester, amide or carbamoyl tethers. While a medium length 6 atom spacer in the ether series is preferred over shorter spacers for enhanced activity, short (2 atom) to long (11 atom) spacers are effective in the more common carbamoyl series. For largely historic reasons, the dimethylamino head group has remained a popular cationic centre, but several studies have shown that the N-hydroxyethyl secondary amine functionality may be more effective in cytofectins. This observation has been attributed, in part, to the increased hydrophilicity of the head group and facilitated release of the nucleic acid cargo from liposomes in endosomal compartments. However, the hypothesis that the incorporation of each of these favourable chemical features into a single novel cytofectin may lead to superior transfection activity remains to be fully tested.
Export Options
About this article
Cite this article as:
Ariatti Mario, Liposomal Formulation of Monovalent Cholesteryl Cytofectins with Acyclic Head Groups and Gene Delivery: A Systematic Review, Current Pharmaceutical Biotechnology 2015; 16 (10) . https://dx.doi.org/10.2174/1389201016666150629103059
DOI https://dx.doi.org/10.2174/1389201016666150629103059 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents DNA Methylation Markers in Lung Cancer
Current Genomics Carbon Nanotube: A Versatile Carrier for Various Biomedical Applications
Drug Delivery Letters Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis
Current Drug Targets Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Platelet-Rich Plasma Induces Mixed Osteogenic/Osteoclastogenic Phenotype in Osteosarcoma SaOS-2 Cells: Role of TGF-Beta
Current Pharmaceutical Biotechnology Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators
Current Topics in Medicinal Chemistry Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews Focal Adhesion Kinase: From In Vitro Studies to Functional Analyses In Vivo
Current Protein & Peptide Science Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer
Current Cancer Drug Targets Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery PI3K Pathway Inhibitors: Better Not Left Alone
Current Pharmaceutical Design Analysis of Glycosaminoglycans by Electrophoretic Approach
Current Pharmaceutical Analysis